Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 2/20 | 0.73 |
| ▸ | TERT | O14746 | 5/20 | 0.61 |
| ▸ | BRD4 | O60885 | 1/20 | 0.61 |
| ▸ | PDE5A | O76074 | 2/20 | 0.58 |
| ▸ | ESR1 | P03372 | 1/20 | 0.58 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.58 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.58 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.55 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.55 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.55 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.53 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.53 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.53 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.53 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.53 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.52 |
| ▸ | TNKS | O95271 | 1/20 | 0.50 |
| ▸ | PARP1 | P09874 | 1/20 | 0.50 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.50 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27013490 | 1.00 | AKT1 (0.73) | AKT1TERTBRD4PDE5AESR1 | |
| SCHEMBL4214011 | 0.91 | PDE5A (0.71) | AKT1TERTBRD4PDE5AESR1 | |
| SCHEMBL3192637 | 0.89 | PDE5A (0.60) | AKT1TERTBRD4PDE5AESR1 | |
| SCHEMBL3181663 | 0.88 | PDE5A (0.59) | AKT1TERTBRD4PDE5AESR1 | |
| SCHEMBL3188097 | 0.86 | PDE5A (0.56) | AKT1TERTBRD4PDE5AESR1 | |
| SCHEMBL3181023 | 0.85 | PDE5A (0.56) | AKT1TERTBRD4PDE5AESR1 | |
| SCHEMBL4828372 | 0.85 | AKT1 (1.00) | AKT1PDE5AESR1PDE4DESR2 | |
| SCHEMBL3174917 | 0.82 | KDM4E (0.54) | AKT1TERTPDE5AESR1PDE4D | |
| SCHEMBL7374824 | 0.81 | TERT (0.65) | AKT1TERTBRD4MCL1CSNK2A2 | |
| SCHEMBL13532130 | 0.81 | KDM4E (0.56) | AKT1PDE5AESR1PDE4DESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4543220-A2 | COMPOSITIONS FOR REDUCING METHANE EMISSIONS, ANIMAL FEEDS COMPRISING THEM AND THEIR USE TO REDUCE METHANE EMISSIONS | Mootral Innovations Limited (GB) | 2025-04-30 | — | — | EP | claimed |
| WO-2023247942-A2 | COMPOSITIONS FOR REDUCING METHANE EMISSION | Mootral Innovations Limited (GB) | 2023-12-28 | — | — | WO | claimed |
| EP-4543220-A2 | COMPOSITIONS FOR REDUCING METHANE EMISSIONS, ANIMAL FEEDS COMPRISING THEM AND THEIR USE TO REDUCE METHANE EMISSIONS | Mootral Innovations Limited (GB) | 2025-04-30 | — | — | EP | disclosed |
| US-20240016777-A1 | COMPOUNDS AND METHODS FOR TREATING VIRAL INFECTIONS | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 2024-01-18 | — | — | US | disclosed |
| WO-2023247942-A2 | COMPOSITIONS FOR REDUCING METHANE EMISSION | Mootral Innovations Limited (GB) | 2023-12-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240016777-A1 | COMPOUNDS AND METHODS FOR TREATING VIRAL INFECTIONS | THPO, SERPINB1, SERPINC1 | AKT1 4428/4885TERT 925/4885BRD4 2147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.